Back to rankings

Nordson Corporation (NDSN)

POSITIVE
IndustrialsSpecialty Industrial MachineryUnited States

Fundamental

70

Price

$333.71

Market Cap

$18.51B

Part 1 · What the company is worth

Overview

Nordson makes precision dispensing equipment: machines that apply exact, controlled amounts of adhesives, coatings, sealants and other fluids inside a factory line, plus components used in medical devices and semiconductor manufacturing. Its products are typically a small line item inside a much larger production process — a diaper plant's glue applicator, a chip packaging step, a catheter's plastic tubing — but a failure or imprecision there can shut the whole line down.

How it makes money

Revenue comes mostly from selling dispensing systems and components once, plus recurring sales of spare parts, nozzles and service that keep those systems running precisely over years of use. Because customers integrate Nordson's equipment into a validated production process, replacing it later requires re-qualifying the whole line, which supports steady repeat business rather than one-off equipment sales.

Revenue by segment

Industrial Precision Solutions48%

Adhesive, coating and sealant dispensing systems sold into packaging, general industrial and consumer goods production lines.

Medical and Fluid Solutions30%

Components and precision fluid-management systems used in medical devices such as catheters, plus fluid dispensing for other industries.

Advanced Technology Solutions22%

Equipment used in semiconductor and electronics manufacturing, including chip packaging and testing steps.

Competitive moat

Switching costs · Narrow

Once a customer validates a production line around Nordson's dispensing equipment — calibrated to exact fluid volumes and tolerances, sometimes under regulatory approval as in medical devices — swapping to a competitor means re-validating the whole line, a costly and slow process manufacturers avoid unless something is badly wrong. That keeps replacement parts and service revenue sticky even where the original equipment sale was competitive.

What drives demand

Moderately cyclical

Demand splits between steadier end markets — packaging, medical devices, consumer nondurables — and more cyclical ones like semiconductor and electronics capital spending, which swings with chip industry investment cycles. The mix of the three segments smooths some of that cyclicality but does not remove it, particularly in the Advanced Technology segment.

Key risks

  • Cyclicality in semiconductor capital spending — The Advanced Technology Solutions segment depends on chip makers' capital equipment budgets, which are historically volatile and can swing sharply between shortage and oversupply periods.
  • Acquisition integration risk — Nordson has grown its segments partly through acquisitions; integrating acquired businesses' operations, systems and customer relationships carries execution risk and can strain expected returns.
  • Customer capital spending decisions — Equipment sales depend on customers deciding to build or upgrade production lines, decisions that can be postponed in an uncertain economic environment even when replacement parts demand continues.
  • International operations and currency exposure — A significant share of sales and manufacturing occurs outside the United States, exposing results to currency translation and to economic and trade conditions in those markets.

The case for

Buyers argue that Nordson's equipment gets embedded in validated production lines across three diversified end markets, that recurring parts and service revenue smooths the cycle, and that record fiscal 2025 results show the model compounding through both steadier and more cyclical segments at once.

The case against

Sellers fear that the Advanced Technology segment remains exposed to a genuinely volatile semiconductor capital-spending cycle, that growth built partly through acquisitions carries integration risk that can disappoint, and that a broader industrial slowdown would delay the equipment upgrades that drive the larger, steadier segments too.

Written by the editors, published on August 18, 2026

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balance Sheet & Liquidity

Revenue

$2.98B

Trailing 12 months (through 7/31/2026)

Net Income

$555M

Trailing 12 months (through 7/31/2026)

Free Cash Flow

$661M

Total Equity

$3.04B

Total Liabilities

$2.87B

Current Ratio

1.82

Interest Coverage

8.83

Debt/EBITDA

2.30

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Historical statement

Margins over time

Debt over time

How heavy the debt is

Growth grid

Growth — Revenue

Fair Value Estimation

Fairly Valued

Fair Value

$291.28

Current Price

$333.71

Margin of Safety

-14.6%

Fair Value Range

$219.91 - $362.64

Estimation Methods

Analyst Target:$349.71
DCF:$316.90
PE-based:$236.73
Graham Growth:$331.27
EPV:$104.31
Analyst Consensus:Buy (10B / 5H / 0S)
Last Earnings Surprise:+2.66%

Valuation Metrics

P/E Ratio

33.83

ROE

15.9%

P/B Ratio

5.69

P/FCF

25.69

Gross Margin

55.3%

ROIC

12.1%

Profitability Radar

Value Creation (Economic Moat)

ROIC

12.1%

WACC

9.5%

ROIC − WACC

+2.6 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Fundamental Analysis Criteria

Passed (21)

  • EPS shows upward trend
  • EPS CAGR 5.49%
  • Price CAGR 11.48%
  • ROIC 12.1%
  • Gross Margin 55.3%
  • P/FCF 25.69
  • Debt/Equity ratio
  • Operating Margin 26.9%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 17.1%
  • Revenue Growth 5Y 5.7%
  • Analyst Consensus 67% Buy
  • Earnings Quality (OCF/NI) 1.39
  • Share Dilution -1.2%
  • Net Margin Trend 18.6% vs 16.3%
  • Piotroski F-Score 7/9

Failed (6)

  • P/B Ratio 5.69
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.3%
  • PEG Ratio 2.19

Unavailable (1)

  • Dividend Payout NaN%

Piotroski F-Score

7/9

Strong financial health

score
criteria

Earnings Quality

1.39

High quality: earnings backed by cash

Share Dilution

-1.2%

Buying back shares. Shareholder friendly

Governance

Executive Team

NameTitleAge
Mr. Sundaram NagarajanPresident, CEO & Director62
Mr. Daniel R. HopgoodExecutive VP & CFO52
Ms. Jennifer L. McDonough J.D.Executive VP, General Counsel & Corporate Secretary53
Mr. Joseph P. KelleyExecutive VP of Industrial Precision Solutions Leader52
Mr. Joseph M. RutledgeVP & Chief Accounting Officer45
Ms. Lara L. MahoneyVice President of Investor Relations & Corporate Communications-
Katie ColacarroVice President of Corporate Development-
Ms. Sarah SiddiquiExecutive VP & Chief Human Resources Officer47
Mr. Justin HallExecutive Vice President of Medical & Fluid Solutions46

Audit Risk

9

Board Risk

3

Compensation Risk

6

Shareholder Rights Risk

10

Part 2 · The price and when to enter

This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.

Latest News

Recent headlines for NDSN, sourced from Markets Gazette.

  • 4d agoPOSITIVE
    Thursday’s Activity, 4 Possible Friday Plays

    Nordson Corporation (NDSN) was highlighted as a potential multi-bagger opportunity in Thursday's trading session, with the NDSN Weekly $310-320 call options showing significant upside potential. The article suggests that the stock has delivered strong performance, aligning with the firm's successful track record of identifying profitable trading plays. Investors who followed this recommendation may have seen substantial gains, indicating positive momentum for the company's stock.

via Markets Gazette